VIA ELECTRONIC TRANSMISSION
- The Honorable Earl L. “Buddy” Carter
Chair
Subcommittee on Health
Committee on Energy and Commerce
U.S. House of Representatives
Washington, D.C. 20515 - The Honorable Diana DeGette
Ranking Member
Subcommittee on Health
Committee on Energy and Commerce
House of Representatives
Washington, D.C. 20515
Dear Chairman Carter and Ranking Member DeGette:
On behalf of the undersigned organizations, we appreciate your leadership in addressing the fentanyl epidemic, a crisis that has devastated families across the country, and for convening the hearing entitled, Combatting Existing and Emerging Illicit Drug Threats, scheduled for Thursday, February 6, 2025. 1 As physicians, we write to provide a clinical perspective on this issue, particularly regarding our compliance with the Controlled Substances Act (CSA) and the critical distinction between fentanyl approved by the U.S. Food and Drug Administration (FDA) and illicit fentanyl analogues.2
Click here to view the full Neurosurgery Submits Comment to Energy and Commerce Subcommittee on Health Hearing on Illicit Drug Threats.
